|
2-(1,3-benzoxazol-2-ylsulfanyl)-N-phenylacetamide |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
2-(7-acetyl-3-benzyl-2,4-dioxo-3,4,5,6,7,8-hexahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-1(2H)-yl)-N-(3-fluoro-4-methylphenyl)acetamide |
Depiction based on curated SMILES
N
H
O
N
O
H
3
C
F
H
O
N
S
H
3
C
O
N
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
2-(1H-benzimidazol-2-ylsulfanyl)-N-(3,4-dichlorophenyl)acetamide |
Depiction based on curated SMILES
Cl
Cl
NH
N
H
O
N
S
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
2-(1H-benzimidazol-2-ylthio)-N-[3-(methylthio)phenyl]acetamide |
Depiction based on curated SMILES
S
N
H
N
CH
3
O
N
H
S
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
2-(1H-benzimidazol-2-ylsulfanyl)-N-(4-bromophenyl)acetamide |
Depiction based on curated SMILES
Br
HN
N
H
O
N
S
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
Acetamide, 2-(1H-benzimidazol-2-ylthio)-N-(4-chlorophenyl)- |
Depiction based on curated SMILES
Cl
HN
N
H
O
N
S
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
2-(1H-benzimidazol-2-ylsulfanyl)-N-(4-cyanophenyl)acetamide |
Depiction based on curated SMILES
N
H
N
N
S
O
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
Acetamide, 2-(1H-benzimidazol-2-ylthio)-N-phenyl- |
Depiction based on curated SMILES
NH
N
H
O
N
S
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
N-Isopropyl-2,3-dioxoindoline-1-acetamide |
Depiction based on curated SMILES
O
O
CH
3
N
O
N
H
CH
3
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
von Ambüren J, et al. 2020. Microorganisms |
|
2,2'-thiobis(4-methylphenol) |
Depiction based on curated SMILES
OH
CH
3
CH
3
S
HO
|
Pseudomonas Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Jessen DL, et al. 2014. Antimicrob Agents Chemother
|
|
| | |